Terms: = Endocrine gland cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717
170 results:
1. Sciellin promotes the development and progression of thyroid cancer through the jak2/STAT3 signaling pathway.
Guo H; Wang Z; Yin K; Ma R; Zhang Y; Yin F; Li H; Yin D
Mol Carcinog; 2024 Apr; 63(4):701-713. PubMed ID: 38411346
[TBL] [Abstract] [Full Text] [Related]
2. WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with Stathmin.
Yang J; Li N; Zhao X; Guo W; Wu Y; Nie C; Yuan Z
Biochem Pharmacol; 2024 Mar; 221():116040. PubMed ID: 38311257
[TBL] [Abstract] [Full Text] [Related]
3. The association between hepatic viral infections and cancers: a cross-sectional study in the Taiwan adult population.
Maliko M; Su FH; Kamiza AB; Su MJ; Yeh CC
Clin Exp Med; 2024 Jan; 24(1):20. PubMed ID: 38279980
[TBL] [Abstract] [Full Text] [Related]
4. Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the jak2/STAT3 pathway.
Luo X; Ye Z; Xu C; Chen H; Dai S; Chen W; Bao G
Mol Biol Rep; 2024 Jan; 51(1):176. PubMed ID: 38252208
[TBL] [Abstract] [Full Text] [Related]
5. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the jak2/STAT3 pathway and interacting with ESM1.
Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J
J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795
[TBL] [Abstract] [Full Text] [Related]
6. [Etiological analysis of a patient with multiple primary malignant neoplasms].
Shi PJ; Li YB; Xiao HP
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(47):3848-3851. PubMed ID: 38123227
[TBL] [Abstract] [Full Text] [Related]
7. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract] [Full Text] [Related]
8. 3'-Hydroxypterostilbene Potently Suppresses Tumor Growth via Inhibiting the Activation of the jak2/STAT3 Pathway in Ovarian Clear Cell Carcinoma.
Koh YC; Huang WZ; Nagabhushanam K; Ho CT; Pan MH
Mol Nutr Food Res; 2024 Jan; 68(1):e2300108. PubMed ID: 37876143
[TBL] [Abstract] [Full Text] [Related]
9. Pre- and Postoperative Magnetic Resonance Imaging Comparative Studies of Pituitary Tissues Following Transsphenoidal Resection of Pituitary Macroadenomas.
Xiao D; Zhang S; Lin K; Zhao L; Wei L; Wang S
J Integr Neurosci; 2023 Aug; 22(5):107. PubMed ID: 37735115
[TBL] [Abstract] [Full Text] [Related]
10. Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cells.
Goad DW; Nesmelova AY; Yohe LR; Grdzelishvili VZ
J Virol; 2023 Sep; 97(9):e0100523. PubMed ID: 37671865
[TBL] [Abstract] [Full Text] [Related]
11. Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-jak2-STAT3 axis.
Sarwar A; Zhu Z; Zhu M; Tang X; Su Q; Yang T; Tang W; Zhang Y
J Pharm Pharmacol; 2023 Oct; 75(10):1294-1309. PubMed ID: 37463100
[TBL] [Abstract] [Full Text] [Related]
12. SPIB Knockdown Inhibits the Immune Escape of Ovarian cancer Cells by Reducing PD-L1 (CD274) Expression and Inactivating the JAK/STAT Pathway.
Gu W; Qi G; Chen L
Iran J Immunol; 2023 Sep; 20(3):335-347. PubMed ID: 37452634
[TBL] [Abstract] [Full Text] [Related]
13. BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.
Huang C; Li H; Xu Y; Xu C; Sun H; Li Z; Ge Y; Wang H; Zhao T; Gao S; Wang X; Yang S; Sun P; Liu Z; Liu J; Chang A; Hao J
Signal Transduct Target Ther; 2023 Jul; 8(1):271. PubMed ID: 37443111
[TBL] [Abstract] [Full Text] [Related]
14. The Experience of a Single Tertiary Center Regarding Benign and Malignant Tumors in Acromegalic Patients.
Plotuna IS; Balas M; Golu I; Amzar D; Vlad A; Moleriu LC; Vlad M
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374352
[No Abstract] [Full Text] [Related]
15. Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of Pancreatic Ductal Adenocarcinoma.
Kong Y; Luo Y; Zheng S; Yang J; Zhang D; Zhao Y; Zheng H; An M; Lin Y; Ai L; Diao X; Lin Q; Chen C; Chen R
Cancer Res; 2023 Sep; 83(18):3077-3094. PubMed ID: 37363990
[TBL] [Abstract] [Full Text] [Related]
16. A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer.
Liu F; Xiang Q; Luo Y; Luo Y; Luo W; Xie Q; Fan J; Ran H; Wang Z; Sun Y
J Nanobiotechnology; 2023 May; 21(1):165. PubMed ID: 37221521
[TBL] [Abstract] [Full Text] [Related]
17. The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer.
Entrialgo-Cadierno R; Cueto-Ureña C; Welch C; Feliu I; Macaya I; Vera L; Morales X; Michelina SV; Scaparone P; Lopez I; Darbo E; Erice O; Vallejo A; Moreno H; Goñi-Salaverri A; Lara-Astiaso D; Halberg N; Cortes-Dominguez I; Guruceaga E; Ambrogio C; Lecanda F; Vicent S
Mol Cancer; 2023 May; 22(1):86. PubMed ID: 37210549
[TBL] [Abstract] [Full Text] [Related]
18. Ginkgetin suppresses ovarian cancer growth through inhibition of jak2/STAT3 and MAPKs signaling pathways.
Wu L; Qian C; Zhang W; Shi M; Chen X; Wang Y; Lin F
Phytomedicine; 2023 Jul; 116():154846. PubMed ID: 37172479
[TBL] [Abstract] [Full Text] [Related]
19. OTX1 silencing suppresses ovarian cancer progression through inhibiting the JAK/STAT signaling.
Zhang Q; Li X; Ren L; Gu X; Xiao N; Li N
Tissue Cell; 2023 Jun; 82():102082. PubMed ID: 37027968
[TBL] [Abstract] [Full Text] [Related]
20. STAT3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target.
Al-Hetty HRAK; Abdulameer SJ; Alkubaisy SA; Zaid SA; Jalil AT; Jasim IK
Pathol Res Pract; 2023 May; 245():154425. PubMed ID: 37019018
[TBL] [Abstract] [Full Text] [Related]
[Next]